tiprankstipranks
Advertisement
Advertisement

RARE Stock Latest News

Ultragenyx: Strong Commercial Momentum and Diversified Late-Stage Pipeline Support Buy Rating and Unchanged $67 Price Target
RatingsUltragenyx: Strong Commercial Momentum and Diversified Late-Stage Pipeline Support Buy Rating and Unchanged $67 Price Target
20h ago
RARE
Ultragenyx price target raised to $81 from $79 at Canaccord
PremiumThe Fly
Ultragenyx price target raised to $81 from $79 at Canaccord
22h ago
RARE
Ultragenyx price target lowered to $45 from $47 at Wells Fargo
PremiumThe Fly
Ultragenyx price target lowered to $45 from $47 at Wells Fargo
23h ago
RARE
Ultragenyx: Strong Q2 Beat, Clear Path to FY27 Profitability and Catalyst-Rich 2H26 Support Buy Rating
PremiumRatings
Ultragenyx: Strong Q2 Beat, Clear Path to FY27 Profitability and Catalyst-Rich 2H26 Support Buy Rating
1d ago
RARE
Closing Bell Movers: SpaceX slips after first quarterly report as public company
PremiumThe Fly
Closing Bell Movers: SpaceX slips after first quarterly report as public company
1d ago
CC
AMD
Ultragenyx reports Q2 EPS ($0.90), consensus ($1.24)
PremiumThe FlyUltragenyx reports Q2 EPS ($0.90), consensus ($1.24)
2d ago
RARE
Ultragenyx reaffirms FY26 revenue view $730M-$760M, consensus $748.3M
Premium
The Fly
Ultragenyx reaffirms FY26 revenue view $730M-$760M, consensus $748.3M
2d ago
RARE
Ultragenyx price target lowered to $35 from $43 at Guggenheim
Premium
The Fly
Ultragenyx price target lowered to $35 from $43 at Guggenheim
2d ago
RARE
Is RARE a Buy, Before Earnings?
PremiumPre-Earnings
Is RARE a Buy, Before Earnings?
4d ago
RARE
Ultragenyx Pharmaceutical, Inc. (RARE) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Ultragenyx Pharmaceutical, Inc. (RARE) Q2 Earnings Cheat Sheet
9d ago
RARE
Ultragenyx price target raised to $30 from $26 at Wedbush
PremiumThe Fly
Ultragenyx price target raised to $30 from $26 at Wedbush
24d ago
RARE
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
PremiumWeekend Updates
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
26d ago
ASX
YPF
Ultragenyx price target raised to $40 from $35 at RBC Capital
PremiumThe FlyUltragenyx price target raised to $40 from $35 at RBC Capital
30d ago
RARE
Ultragenyx: Favorable Risk-Reward Ahead of GTX-102 ASPIRE Readout, Analyst Reiterates Buy and $72 Price Target
Premium
Ratings
Ultragenyx: Favorable Risk-Reward Ahead of GTX-102 ASPIRE Readout, Analyst Reiterates Buy and $72 Price Target
30d ago
RARE
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
2M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
2M ago
AZN
BMY
Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald
PremiumThe Fly
Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald
3M ago
RARE
Ultragenyx Earnings Call Balances Growth and Cash Burn
PremiumCompany Announcements
Ultragenyx Earnings Call Balances Growth and Cash Burn
3M ago
RARE
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors
PremiumCompany Announcements
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors
3M ago
8K
RARE
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe FlyTrump Trade: Trump to suspend tariff-rate quotas on beef imports
3M ago
AZN
BMY
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
3M ago
DYN
RNA
Ultragenyx price target lowered to $33 from $34 at Evercore ISI
Premium
The Fly
Ultragenyx price target lowered to $33 from $34 at Evercore ISI
3M ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >